Hong Kong-listed pharma WuXi AppTec is investing $5 million in Creacion Ventures I as it joins over a dozen limited partners (LPs) to build a $200-million life science fund to tap investment opportunities in Greater China, North America and European Union (EU).
Start your deal-making journey now!
Subscribe now to enjoy unlimited access at just $59.
Premium coverage on private equity, venture capital, and startups in Asia.
Exclusive scoops from our reporters in nine key markets.
In-depth interviews with industry leaders shaping the ecosystem.
Already a Subscriber? Log in
Contact us for corporate subscriptions at subs@dealstreetasia.com
